Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Identifying Host Factors Associated with DNA Replicated During Virus Infection.

Reyes ED, Kulej K, Pancholi NJ, Akhtar LN, Avgousti DC, Kim ET, Bricker DK, Spruce LA, Koniski SA, Seeholzer SH, Isaacs SN, Garcia BA, Weitzman MD.

Mol Cell Proteomics. 2017 Dec;16(12):2079-2097. doi: 10.1074/mcp.M117.067116. Epub 2017 Oct 2.

PMID:
28972080
2.

A novel target and approach for identifying antivirals against molluscum contagiosum virus.

Guan H, Nuth M, Zhukovskaya N, Saw YL, Bell E, Isaacs SN, Ricciardi RP.

Antimicrob Agents Chemother. 2014 Dec;58(12):7383-9. doi: 10.1128/AAC.03660-14. Epub 2014 Sep 29.

3.

Adsorption of recombinant poxvirus L1-protein to aluminum hydroxide/CpG vaccine adjuvants enhances immune responses and protection of mice from vaccinia virus challenge.

Xiao Y, Zeng Y, Alexander E, Mehta S, Joshi SB, Buchman GW, Volkin DB, Middaugh CR, Isaacs SN.

Vaccine. 2013 Jan 2;31(2):319-26. doi: 10.1016/j.vaccine.2012.11.007. Epub 2012 Nov 12.

4.

Enzyme-linked immunosorbent assay (ELISA) and blocking with bovine serum albumin (BSA)--not all BSAs are alike.

Xiao Y, Isaacs SN.

J Immunol Methods. 2012 Oct 31;384(1-2):148-51. doi: 10.1016/j.jim.2012.06.009. Epub 2012 Jun 23.

5.

Working safely with vaccinia virus: laboratory technique and review of published cases of accidental laboratory infections.

Isaacs SN.

Methods Mol Biol. 2012;890:1-22. doi: 10.1007/978-1-61779-876-4_1. Review.

PMID:
22688758
6.

Elucidating the role of the complement control protein in monkeypox pathogenicity.

Hudson PN, Self J, Weiss S, Braden Z, Xiao Y, Girgis NM, Emerson G, Hughes C, Sammons SA, Isaacs SN, Damon IK, Olson VA.

PLoS One. 2012;7(4):e35086. doi: 10.1371/journal.pone.0035086. Epub 2012 Apr 9.

7.

Treating tumors with a vaccinia virus expressing IFN╬▓ illustrates the complex relationships between oncolytic ability and immunogenicity.

Wang LC, Lynn RC, Cheng G, Alexander E, Kapoor V, Moon EK, Sun J, Fridlender ZG, Isaacs SN, Thorne SH, Albelda SM.

Mol Ther. 2012 Apr;20(4):736-48. doi: 10.1038/mt.2011.228. Epub 2011 Oct 18.

8.

The vaccinia virus A56 protein: a multifunctional transmembrane glycoprotein that anchors two secreted viral proteins.

Dehaven BC, Gupta K, Isaacs SN.

J Gen Virol. 2011 Sep;92(Pt 9):1971-80. doi: 10.1099/vir.0.030460-0. Epub 2011 Jun 29. Review.

9.

Antibody against extracellular vaccinia virus (EV) protects mice through complement and Fc receptors.

Cohen ME, Xiao Y, Eisenberg RJ, Cohen GH, Isaacs SN.

PLoS One. 2011;6(6):e20597. doi: 10.1371/journal.pone.0020597. Epub 2011 Jun 8.

10.
11.

The Vaccinia virus complement control protein modulates adaptive immune responses during infection.

Girgis NM, Dehaven BC, Xiao Y, Alexander E, Viner KM, Isaacs SN.

J Virol. 2011 Mar;85(6):2547-56. doi: 10.1128/JVI.01474-10. Epub 2010 Dec 29.

12.

A stimulating way to improve T cell responses to poxvirus-vectored vaccines.

Isaacs SN.

J Clin Invest. 2011 Jan;121(1):19-21. doi: 10.1172/JCI45726. Epub 2010 Dec 22.

13.

Poxvirus complement control proteins are expressed on the cell surface through an intermolecular disulfide bridge with the viral A56 protein.

DeHaven BC, Girgis NM, Xiao Y, Hudson PN, Olson VA, Damon IK, Isaacs SN.

J Virol. 2010 Nov;84(21):11245-54. doi: 10.1128/JVI.00372-10. Epub 2010 Aug 18.

14.

A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge.

Buchman GW, Cohen ME, Xiao Y, Richardson-Harman N, Silvera P, DeTolla LJ, Davis HL, Eisenberg RJ, Cohen GH, Isaacs SN.

Vaccine. 2010 Sep 14;28(40):6627-36. doi: 10.1016/j.vaccine.2010.07.030. Epub 2010 Jul 24.

15.

Listeria monocytogenes delivery of HPV-16 major capsid protein L1 induces systemic and mucosal cell-mediated CD4+ and CD8+ T-cell responses after oral immunization.

Mustafa W, Maciag PC, Pan ZK, Weaver JR, Xiao Y, Isaacs SN, Paterson Y.

Viral Immunol. 2009 Jun;22(3):195-204. doi: 10.1089/vim.2008.0071.

16.

A role for the host coatomer and KDEL receptor in early vaccinia biogenesis.

Zhang L, Lee SY, Beznoussenko GV, Peters PJ, Yang JS, Gilbert HY, Brass AL, Elledge SJ, Isaacs SN, Moss B, Mironov A, Hsu VW.

Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):163-8. doi: 10.1073/pnas.0811631106. Epub 2008 Dec 24.

17.

Monkeypox virus and insights into its immunomodulatory proteins.

Weaver JR, Isaacs SN.

Immunol Rev. 2008 Oct;225:96-113. doi: 10.1111/j.1600-065X.2008.00691.x. Review.

18.

Cell surface expression of the vaccinia virus complement control protein is mediated by interaction with the viral A56 protein and protects infected cells from complement attack.

Girgis NM, Dehaven BC, Fan X, Viner KM, Shamim M, Isaacs SN.

J Virol. 2008 May;82(9):4205-14. doi: 10.1128/JVI.02426-07. Epub 2008 Feb 20.

19.

The identification and characterization of a monoclonal antibody to the vaccinia virus E3 protein.

Weaver JR, Shamim M, Alexander E, Davies DH, Felgner PL, Isaacs SN.

Virus Res. 2007 Dec;130(1-2):269-74. Epub 2007 Jun 20.

20.

Major neutralizing sites on vaccinia virus glycoprotein B5 are exposed differently on variola virus ortholog B6.

Aldaz-Carroll L, Xiao Y, Whitbeck JC, de Leon MP, Lou H, Kim M, Yu J, Reinherz EL, Isaacs SN, Eisenberg RJ, Cohen GH.

J Virol. 2007 Aug;81(15):8131-9. Epub 2007 May 23.

Supplemental Content

Loading ...
Support Center